{"twitch"=>"", "youtube"=>"", "linkedin"=>"https://ca.linkedin.com/in/premnichani", "flickr"=>"", "bio"=>"", "reddit"=>"", "facebook"=>"https://www.facebook.com/prem.nichani", "website"=>"https://premnichani.ca", "twitterinfo"=>"", "othersocialmedia"=>"http://scholar.google.ca/citations?user=6p1d3HwAAAAJ&hl=en", "instagram"=>""}
Sessions auxquelles Prem Nichani participe
Vendredi 10 Juin, 2022
Authors: Prem A. H. Nichani1, Benjamin Solomon2, Tanya Trinh3, Michael Mimouni4, David Rootman1, Neera Singal1, Clara C. Chan1. 1Department of Ophthalmology & Vision Sciences, Temerty Faculty of Medicine, University of Toronto, 2Undergraduate Medical Education, Temerty Faculty of Medicine, University of Toronto, 3Sydney Hospital and Sydney Eye Hospital, 4Rambam Health Care Campus.
Sessions auxquelles Prem Nichani assiste
Vendredi 10 Juin, 2022
Au cours de ce symposium présenté durant le petit déjeuner, des femmes inspirantes partageront leur vision avec nous. Vous découvrirez jusqu’où leur enthousiasme contagieux pourrait vous mener. Laissez-les vous transformer par leur présence et leur puissante énergie. Objectifs d'apprentissageÀ la fin de la séance, les participants pourront :Apprendre au moyen d’exemples de carrières diversifiées.
Learning ObjectivesAt the end of this session, participants will be able to:Determine the ocular conditions associated with obstructive sleep apneaDescribe how racism operates within health care in parallel ways to how racism operates in other settingsProvide a framework for how we can move from supportive statements to anti-racist actionCanMEDS Roles: Medical Expert, Scholar
Learning Objectives:1. To understand the role of genetics and environmental factors in keratoconus.2. To review modalities for refractive surgery and keratoconus management. CanMEDS Roles: Medical expert; Scholar
Learning ObjectivesAt the end of this symposium, participants will be able to:Describe the impact of racism in medicine and healthcare, and identify approaches towards active anti-racismDescribe emerging research on gender equity in ophthalmologyApply best practices to become effective allies and advocates in the healthcare setting, with a special emphasis on the needs of vulnerable populationsIntegrate Indigenous health concep...
Samedi 11 Juin, 2022
Objectifs d’apprentissageÀ la fin de la session, les participants pourront :Repérer des propositions canadiennes novatrices de recherche en rétine et les avantages escomptésDécrire comment l’utilisation des innovations numériques en ophtalmologie peut optimiser les soins aux patientsRôles CanMEDS : Érudit, expert médicale Le présent symposium a été élaboré conjointement avec la SCO et Bayer de man...
Authors: Geoff Williams, Philip J. Ferrone, Charles C. Wykoff, Ramin Tadayoni, Zdenka Haskova, David Silverman, Jane Ives, Karen Basu, Hugh Lin. Author Disclosure Block: G. Williams: Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s); Bayer Novartis Roche. Membership on advisory boards or speakers’ bureaus; Description of relationship(s); Advisory Board. Funded grants or clinic...
Authors: Nishaant Bhambra, Carolina L. M. Francisconi, Samara B. Marafon, Natalia A. Figueiredo, Verena R. Juncal, Rajeev H. Muni.Author Disclosure Block: N. Bhambra: None. C.L.M. Francisconi: None. S.B. Marafon: None. N.A. Figueiredo: None. V.R. Juncal: None. R.H. Muni: Funded grants or clinical trials; Name of for-profit or not-for-profit organization(s); Retina Foundation of Canada. Funded grants or clinical trials; Description of relationship(s); G...
Authors: Rosanna K. Martens, Chao Chen, David Ehmann, Mark Greve, Mark E. Seamone. Author Disclosure Block: R.K. Martens: None. C. Chen: None. D. Ehmann: None. M. Greve: None. M.E. Seamone: None.Purpose: To investigate the anatomic and visual outcomes of individuals undergoing pars plana vitrectomy (PPV) for uncomplicated, primary macula-off rhegmatogenous retinal detachment (RRD) with and without macular internal limiting...
Objectifs d'apprentissageÀ la fin de cette séance, les participants seront en mesure de faire ce qui suit :Définir des façons d’optimiser les résultats des chirurgies de la cataracteExaminer les pathologies comorbides courantes présentes chez les patients atteints de cataracteDécrire les nouveautés technologiques en matière de LIORôles CanMEDS: Expert médical, Érudit...
Dimanche 12 Juin, 2022
LEARNING OBJECTIVESAt the end of this symposium, participants will be able to:Identify the critical unmet needs in neovascular AMD and DME managementDemonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME managementExamine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DMEApply new insights from multi-modal imagin...
Learning ObjectivesAt the end of this session, participants will be able to:Utilize OCT Imaging to differentiate various types of Pigmented Epithelial DetachmentsUtilize OCT Imaging of the choroid...
Learning Objectives:At the end of this session participants will be able to:• Describe the impact of visual impairment on overall health maintenance• Understand the unique aspect of eye health needs in vulnerable populations such as homelessness• Describe the Canadian human resource landscape and challenges augmented by COVID. CanMEDS Roles: Health Advocate, Collaborator
Learning Objectives:At the end of this session participants will be able to:• Understand the specific niche that an academic global ophthalmologist fills• Describe various possible career paths and training in global ophthalmology• Demonstrate how technology can increase access to eye health CanMEDS Roles: Health Advocate, Collaborator
Objectifs d'apprentissageÀ la fin de cette séance, les participants seront en mesure de faire ce qui suit :Explorer des pratiques établies et plus récentes en matière de cataracteExaminer la recherche se rapportant aux pratiques en matière de chirurgie de la cataracteGérer des symptômes courants et rares à la suite d’une chirurgie de la cataracteRôles CanMEDS: Expert médical, Érudit
Learning ObjectivesAt the end of this session, participants will be able to:Discuss established therapeutic options for idiopathic intracranial hypertension (IIH)Summarize recent interventional clinical trials related to IIHDescribe novel targeted disease-modifying therapeutic strategies for IIHCanMEDS Roles: Medical Expert, Collaborator